Yvonne Genzel

Max Planck Institute for Dynamics of Complex Technical Systems — Germany

Biochemistry, Genetics and Molecular Biology · Life Sciences

38h-index4.7kcitations348works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Viral Infectious Diseases and Gene Expression in Insects(148), Influenza Virus Research Studies(97), Virus-based gene therapy research(92), Viral gastroenteritis research and epidemiology(57), Protein purification and stability(34)

Publications347 total

Lipidomic profiling of influenza A virus production in MDCK cells towards targeted clone selection
Scientific Reports·2026Open Access
Optimization of YF17D-Vectored Zika Vaccine Production by Employing Small-Molecule Viral Sensitizers to Enhance Yields
Vaccines·2025· 1 citedOpen Access
High Cell Density Perfusion Process of Quail Cells Producing Oncolytic rVSV‐NDV
Engineering in Life Sciences·2025Open Access
Quantitative analysis of proteomic changes in monoclonal MDCK cell lines infected with human influenza A virus
2025Open Access
Seed Train Intensification and TFDF-Based Perfusion for MDCK Cell-Based Influenza A Virus Production
Processes·2025Open Access
Influenza A Virus Production Following Quality by Design Principles
Engineering in Life Sciences·2025· 1 citedOpen Access
Quantification of intracellular influenza A virus protein dynamics in different host cells after seed virus adaptation
Applied Microbiology and Biotechnology·2025· 2 citedOpen Access
Innovations in cell culture-based influenza vaccine manufacturing – from static cultures to high cell density cultivations
Human Vaccines & Immunotherapeutics·2024· 17 citedOpen Access
Parallel Multifactorial Process Optimization and Intensification for High-Yield Production of Live YF17D-Vectored Zika Vaccine
Vaccines·2024· 2 citedOpen Access
Production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtration
Applied Microbiology and Biotechnology·2024· 11 citedOpen Access
From single‐cell cloning to high‐yield influenza virus production – implementing advanced technologies in vaccine process development
Engineering in Life Sciences·2024· 14 citedOpen Access
Production of antiviral “OP7 chimera” defective interfering particles free of infectious virus
Applied Microbiology and Biotechnology·2024Open Access
Generation of “OP7 chimera” defective interfering influenza A particle preparations free of infectious virus that show antiviral efficacy in mice
Scientific Reports·2023· 6 citedOpen Access
Generation of “OP7 chimera” defective interfering particle preparations free of infectious influenza A virus that shows antiviral efficacy in mice
2023Open Access
Characterization of a quail suspension cell line for production of a fusogenic oncolytic virus
Biotechnology and Bioengineering·2023· 11 citedOpen Access
Production of retroviral vectors in continuous high cell density culture
Applied Microbiology and Biotechnology·2023· 6 citedOpen Access
Novel suspension retroviral packaging cells generated by transposition using transposase encoding mRNA advance vector yields and enable production in bioreactors
Frontiers in Bioengineering and Biotechnology·2023· 6 citedOpen Access
Human 3D Airway Tissue Models for Real-Time Microscopy: Visualizing Respiratory Virus Spreading
Cells·2022· 9 citedOpen Access
Upstream processing for viral vaccines–General aspects
2022· 3 cited
Upstream processing for viral vaccines-Process intensification
2022· 4 cited
page 1 of 18Next →

Frequent Co-authors

Udo Reichl(44), Ingo Jordan(8), Ilona Behrendt(7), Volker Sandig(6), Erdmann Rapp(6), Felipe Tapia(4), Daniel Vázquez-Ramírez(4), J. Schulze‐Horsel(4), Joachim Ritter(3), A. Wahl(3), Alain Archelas(3), Roland Furstoss(3), Alexander Nikolay(3), Verena Lohr(3), J. Schwarzer(3), Susanne König(2), H. Sann(2), Frank S. Heldt(2), Thomas Vogel(2), Gudrun Schiedner(2)